Abstract
Molecular imaging is a broad, multidisciplinary field that aims to discover and apply novel molecules (probes) and methods to image normal and pathological biological processes on a cellular and molecular level in vivo. One might think of molecular imaging as performing histology and pathology without harming the subject. The molecular imaging probes that target specific cells, molecules, or biological events are equivalent to the stains and antibodies used in histology and pathology. The imaging technologies and methods provide the means to visualize these probes and report on the in vivo processes. In this chapter, we cover the basic concepts of molecular imaging and show both the advantages and disadvantages of different imaging approaches. Many techniques and probes can be readily used in preclinical trials to study the efficacy of a drug.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ballou B et al (2004) Noninvasive imaging of quantum dots in mice. Bioconjug Chem 15(1):79–86
Beekman FJ, Vastenhouw B (2004) Design and simulation of a high-resolution stationary SPECT system for small animals. Phys Med Biol 49(19):4579–4592
Behm CZ, Lindner JR (2006) Cellular and molecular imaging with targeted contrast ultrasound. Ultrasound Q 22(1):67–72
Bogdanov A Jr et al (2002) Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging 1(1):16–23
Bouffard J et al (2008) A highly selective fluorescent probe for thiol bioimaging. Org Lett 10(1):37–40
Bruchez M Jr et al (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281(5385):2013–2016
Bruck W et al (1997) Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42(5):783–793
Chen JW et al (2004) Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Reson Med 52(5):1021–1028
Chen W et al (2005) Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. J Nucl Med 46(6):945–952
Chen JW et al (2006) Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 240(2):473–481
Chen JW et al (2008) Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 131(Pt 4):1123–1133
Contag CH, Bachmann MH (2002) Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4:235–260
Corsten MF et al (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67(19):8994–9000
Cotton F et al (2003) MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60(4):640–646
Foster FS et al (2000) Advances in ultrasound biomicroscopy. Ultrasound Med Biol 26(1):1–27
Hall CS, Lanza GM, Rose JH (1977) Experimental determination of phase velocity of perfluorocarbons: applications to targeted contrast agents. Proceedings of the IEEE Ultrasonics Symposium 97CH36118, pp 1605–1608
Herschman HR (2003) Molecular imaging: looking at problems, seeing solutions. Science 302(5645):605–608
Ho NH, Weissleder R, Tung CH (2007) A self-immolative reporter for beta-galactosidase sensing. Chembiochem 8(5):560–566
Hoffman JM, Gambhir SS (2007) Molecular imaging: the vision and opportunity for radiology in the future. Radiology 244(1):39–47
Jacobs AH et al (2005) 18F-Fluoro-l-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med 46(12):1948–1958
Josephson L et al (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10(2):186–191
Jung CW, Jacobs P (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13(5):661–674
Kim S et al (2005) 11C-Methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 32(1):52–59
Kock N et al (2007) Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia 9(5):435–442
Lanza GM, Wickline SA (2001) Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 44(1):13–31
Lauffer RB (1987) Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 87:901–927
Law B, Weissleder R, Tung CH (2007) Protease-sensitive fluorescent nanofibers. Bioconjug Chem 18(6):1701–1704
Lewin M et al (2000) Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18(4):410–414
Lin Y, Weissleder R, Tung CH (2002) Novel near-infrared cyanine fluorochromes: synthesis, properties, and bioconjugation. Bioconjug Chem 13(3):605–610
Merbach AE, Toth E (2001) The chemistry of the contrast agents in medical magnetic resonance imaging. Willey, New York
Moats R et al (1997) A “smart” magnetic resonance imaging agent that reports on specific enzymatic activity. Angew Chem Int Ed Engl 36(7):725–728
Nagra RM et al (1997) Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 78(1–2):97–107
Negrin RS, Contag CH (2006) In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease. Nat Rev Immunol 6(6):484–490
Ntziachristos V (2006) Fluorescence molecular imaging. Annu Rev Biomed Eng 8:1–33
Ntziachristos V et al (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8(7):757–760
Perez JM et al (2002) Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 20(8):816–820
Phelps M (2004) PET: molecular imaging and its biological applications. Springer, New York
Pomper MG (2001) Molecular imaging: an overview. Acad Radiol 8(11):1141–1153
Reimer P et al (1990) Receptor imaging: application to MR imaging of liver cancer. Radiology 177(3):729–734
Rudin M (2005) Molecular imaging. Basic principles and applications in biomedical research. Imperial College Press, London
Rudin M, Weissleder R (2003) Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2(2):123–131
Rychak JJ et al (2007) Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging 6(5):289–296
Schutt EG et al (2003) Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed Engl 42(28):3218–3235
Shah K et al (2005a) Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 57(1):34–41
Shah K et al (2005b) In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Mol Ther 11(6):926–931
Sokoloff L et al (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28(5):897–916
Sun EY, Weissleder R, Josephson L (2006) Continuous analyte sensing with magnetic nanoswitches. Small 2(10):1144–1147
Tang Y et al (2003) In vivo tracking of neural progenitor cell migration to glioblastomas. Hum Gene Ther 14(13):1247–1254
Tjuvajev JG et al (1996) Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res 56(18):4087–4095
Tung CH et al (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60(17):4953–4958
Villanueva FS et al (2007) Myocardial ischemic memory imaging with molecular echocardiography. Circulation 115(3):345–352
Wang DS et al (2006) Molecular imaging: a primer for interventionalists and imagers. J Vasc Interv Radiol 17(9):1405–1423
Weinmann HJ et al (2003) Tissue-specific MR contrast agents. Eur J Radiol 46(1):33–44
Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219(2):316–333
Weissleder R et al (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175(2):489–493
Yoffe A (2001) Semiconductor quantum dots and related systems: electronic, optical, luminiscence and related properties of low dimensional systems. Adv Phys 50:1–208
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rodriguez, E., Chen, J.W. (2010). Molecular Imaging: Basic Approaches. In: Borsook, D., Beccera, L., Bullmore, E., Hargreaves, R. (eds) Imaging in CNS Drug Discovery and Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0134-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0134-7_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0133-0
Online ISBN: 978-1-4419-0134-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)